IVL-745

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameIVL-745
Drug Alias NameIVL-745
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-4/beta-1 antagonists
TargetsIntegrin alpha-4/beta-1
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A